Plasma Dosage of Venetoclax in the Fup of AML Patients Treated With Aza + Ven
Condition:   Acute Myeloid Leukemia Interventions:   Other: Pharmacokinetic sampling;   Other: Vital status determination;   Other: Toxicity assessments;   Drug: Venetoclax and azacitidine combination Sponsor:   Centre Hospitalier Universitaire de Nice Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials

Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy
Conditions:   Chordoma;   Chondrosarcoma;   Ewing Sarcoma;   Osteosarcoma Interventions:   Radiation: Proteus ONE one daily beam;   Radiation: Proteus ONE two daily beam Sponsor:   Centre Antoine Lacassagne Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials

Plasma Dosage of Venetoclax in the Fup of AML Patients Treated With Aza + Ven
Condition:   Acute Myeloid Leukemia Interventions:   Other: Pharmacokinetic sampling;   Other: Vital status determination;   Other: Toxicity assessments;   Drug: Venetoclax and azacitidine combination Sponsor:   Centre Hospitalier Universitaire de Nice Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials

Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy
Conditions:   Chordoma;   Chondrosarcoma;   Ewing Sarcoma;   Osteosarcoma Interventions:   Radiation: Proteus ONE one daily beam;   Radiation: Proteus ONE two daily beam Sponsor:   Centre Antoine Lacassagne Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials

Plasma Dosage of Venetoclax in the Fup of AML Patients Treated With Aza + Ven
Condition:   Acute Myeloid Leukemia Interventions:   Other: Pharmacokinetic sampling;   Other: Vital status determination;   Other: Toxicity assessments;   Drug: Venetoclax and azacitidine combination Sponsor:   Centre Hospitalier Universitaire de Nice Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials

Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy
Conditions:   Chordoma;   Chondrosarcoma;   Ewing Sarcoma;   Osteosarcoma Interventions:   Radiation: Proteus ONE one daily beam;   Radiation: Proteus ONE two daily beam Sponsor:   Centre Antoine Lacassagne Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials

Plasma Dosage of Venetoclax in the Fup of AML Patients Treated With Aza + Ven
Condition:   Acute Myeloid Leukemia Interventions:   Other: Pharmacokinetic sampling;   Other: Vital status determination;   Other: Toxicity assessments;   Drug: Venetoclax and azacitidine combination Sponsor:   Centre Hospitalier Universitaire de Nice Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials

Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy
Conditions:   Chordoma;   Chondrosarcoma;   Ewing Sarcoma;   Osteosarcoma Interventions:   Radiation: Proteus ONE one daily beam;   Radiation: Proteus ONE two daily beam Sponsor:   Centre Antoine Lacassagne Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials

Plasma Dosage of Venetoclax in the Fup of AML Patients Treated With Aza + Ven
Condition:   Acute Myeloid Leukemia Interventions:   Other: Pharmacokinetic sampling;   Other: Vital status determination;   Other: Toxicity assessments;   Drug: Venetoclax and azacitidine combination Sponsor:   Centre Hospitalier Universitaire de Nice Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials

Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy
Conditions:   Chordoma;   Chondrosarcoma;   Ewing Sarcoma;   Osteosarcoma Interventions:   Radiation: Proteus ONE one daily beam;   Radiation: Proteus ONE two daily beam Sponsor:   Centre Antoine Lacassagne Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials

Plasma Dosage of Venetoclax in the Fup of AML Patients Treated With Aza + Ven
Condition:   Acute Myeloid Leukemia Interventions:   Other: Pharmacokinetic sampling;   Other: Vital status determination;   Other: Toxicity assessments;   Drug: Venetoclax and azacitidine combination Sponsor:   Centre Hospitalier Universitaire de Nice Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials

Effects of Probiotic Oral Intake on Plasma Chlordecone (Kepone) Concentrations in Individuals Environmentally Exposed to Pesticide in Martinique.
Condition:   Chlordecone (Kepone) Toxicity Interventions:   Dietary Supplement: Limosilactobacillus reuteri;   Other: Placebo Sponsors:   University Hospital Center of Martinique;   BioGaia AB;   University Hospital, Limoges;   Regional Health Agency, Martinique;   Biological Resource Centre, Martinique;   Clinical Research Vigilance Unit, University Hospital, Reims Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2023 Category: Research Source Type: clinical trials